Rising levels of obesity are set to cost the world economy 3.3 percent of GDP by 2060, slowing development in lower-income countries, according to a study published in BMJ Global Health.
The conditions currently cost 2.2 percent of global GDP, and the biggest increases are expected in lower-resourced countries.
In terms of absolute costs, China, the US, and India are expected to bear the brunt of the damage, with costs of $10 trillion, $2.5 trillion, and $850 billion, respectively.
The worst affected nations are anticipated to be Trinidad and Tobago with 10.2 percent of GDP and the United Arab Emirates with 11.0% of GDP being accounted for by obesity.
Both direct costs, namely medical expenses, and indirect costs from early mortality and lost output were examined in the report.
The study offers the first estimate of the economic effects of obesity, a major contributor to other non-communicable diseases like cancer, diabetes, and heart disorders, on a country-by-country basis.
According to lead author Rachel Nugent at a briefing on the margins of the UN General Assembly, nearly two in three adults globally are now living with obesity and project there would be three in four adults by 2060.


Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady
Thailand Inflation Remains Negative for 10th Straight Month in January
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 



